Abiopharma

News list

(99% Neutral) INDAPTUS THERAPEUTICS, INC. (INDP) Announces New Board Appointment

Full text

News bot Jan. 8, 2026, 10:28 p.m.
📋 INDAPTUS THERAPEUTICS, INC. (INDP) - Executive Changes

Filing Date: 2026-01-08

Accepted: 2026-01-08 17:26:25

Event Type: Executive Changes
Event Details:
Indaptus Therapeutics Inc. (INDP) Announces Executive and Board Changes Indaptus Therapeutics Inc. (INDP) announced changes to its leadership team and board of directors. David Natan was appointed. The position includes: Class II, Audit Committee. The change is effective as of January 8, 2026. Executive Changes Details:
Personnel Involved: David Natan
Actions: Appointed
Committee Assignments: Audit Committee
Effective Date: January 8, 2026
Board Classification: Class II
👥 Executive & Board Changes:
Personnel Involved: David Natan
Actions: Appointed
Committee Assignments: Audit Committee
Effective Dates: January 8, 2026, December 22, 2025
💼 Business Developments:
- Partnership
- Acquisition: Not available
- Licensing: Not available
- Regulatory Approval: Not available
- Executive Changes
Structured Data:
- Company Name: Indaptus Therapeutics Inc.
- CIK: 0001857044
- Ticker Symbol: INDP
- Period End Date: 2026-01-08
- Document Type: 8-K